These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2029018)

  • 21. Microsatellite instability in Muir-Torre syndrome.
    Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN
    Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
    Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
    Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Muir-Torre syndrome. Diagnostic criteria and review of the literature].
    Hartig C; Stieler W; Stadler R
    Hautarzt; 1995 Feb; 46(2):107-13. PubMed ID: 7706067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two patients with Muir-Torre syndrome].
    Vermeer MH; Neering H; Menko FH
    Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1980. PubMed ID: 10610483
    [No Abstract]   [Full Text] [Related]  

  • 25. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Muir-Torre syndrome].
    Tiszlavicz L; Hódi Z; Tihanyi Z
    Orv Hetil; 1999 Jan; 140(5):251-4. PubMed ID: 10064979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Muir-Torre syndrome: a 25-year retrospect.
    Schwartz RA; Torre DP
    J Am Acad Dermatol; 1995 Jul; 33(1):90-104. PubMed ID: 7601953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
    Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
    Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muir-Torre Syndrome.
    Gamret AC; Klingbeil KD; Fertig RM; Jahan-Tigh RR; Silapunt S; Uzoma M; Gaudi S; Romanelli P
    Skinmed; 2020; 18(6):382-384. PubMed ID: 33397571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
    Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
    J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The tip of the iceberg: multiple cutaneous sebaceous tumor in colon cancer. Muir-Torre syndrome--case report].
    Herr G; Szenes M; Hohl G; Vinkler ME; Tüske G; Horváth J; Nagy G; Tihanyi M; Széll M; Nagy N; Gasztonyi B
    Orv Hetil; 2015 Jun; 156(24):979-84. PubMed ID: 26051134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Muir-Torre syndrome. Apropos of a case associated with a familial form of cancer].
    Prunet D; Lehur PA; Guiberteau-Canfrère V; Thébaud Y; Litoux P; Le Borgne J
    Ann Chir; 1992; 46(10):944-6. PubMed ID: 1300910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].
    Demolin G; Romain M; Münschke A; Vandingenen T; Blaude MA; Van Craynest MP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):767-74. PubMed ID: 26321614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
    J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.
    Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ
    Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muir-Torre syndrome: a variant of the cancer family syndrome.
    Hall NR; Williams MA; Murday VA; Newton JA; Bishop DT
    J Med Genet; 1994 Aug; 31(8):627-31. PubMed ID: 7815421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MSH6 mutation in a family affected by Muir-Torre syndrome.
    Kacerovska D; Cerna K; Martinek P; Grossmann P; Michal M; Ricar J; Kazakov DV
    Am J Dermatopathol; 2012 Aug; 34(6):648-52. PubMed ID: 22814321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muir-Torre syndrome in patients with hematologic malignancies.
    Cohen PR
    Am J Hematol; 1992 May; 40(1):64-5. PubMed ID: 1566750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
    Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
    Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.